Your browser doesn't support javascript.
loading
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.
Cawley, Niamh; Tur, Carmen; Prados, Ferran; Plantone, Domenico; Kearney, Hugh; Abdel-Aziz, Khaled; Ourselin, Sebastian; Wheeler-Kingshott, Claudia Am Gandini; Miller, David H; Thompson, Alan J; Ciccarelli, Olga.
Afiliação
  • Cawley N; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK.
  • Tur C; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK.
  • Prados F; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK/Translational Imaging Group, Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London (UCL), London,
  • Plantone D; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK.
  • Kearney H; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK.
  • Abdel-Aziz K; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK.
  • Ourselin S; Translational Imaging Group, Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London (UCL), London, UK.
  • Wheeler-Kingshott CAG; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK.
  • Miller DH; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK/UCL Hospitals Biomedical Research Centre, London, UK.
  • Thompson AJ; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK/UCL Hospitals Biomedical Research Centre, London, UK.
  • Ciccarelli O; Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK/UCL Hospitals Biomedical Research Centre, London, UK.
Mult Scler ; 24(7): 932-941, 2018 06.
Article em En | MEDLINE | ID: mdl-28516804
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Medula Espinal / Avaliação de Resultados em Cuidados de Saúde / Ensaios Clínicos Fase II como Assunto / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Medula Espinal / Avaliação de Resultados em Cuidados de Saúde / Ensaios Clínicos Fase II como Assunto / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article